CoChat

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies

Open access
Thompson, Paul W., Ye, Liang, Morgenstern, Jennifer L., Sue, Lucia, Beach, Thomas G., Judd, Duncan J., Shipley, Nicholas J., Libri, Vincenzo, Lockhart, Andrew · 2009 · Journal of Neurochemistry
Cited by 137

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The distinctive cortical uptake of the tracer 18 F‐FDDNP (2‐(1‐{6‐[(2‐fluoroethyl(methyl)amino]‐2‐naphthyl}ethylidene)malononitrile) in Alzheimer’s disease (AD) is believed to be because of its binding to both neurofibrillary tangles (NFTs) and highly fibrillar senile plaques. We therefore investigated the binding of a tracer concentration of 3 H‐FDDNP to brain sections containing AD hallmark pathologies. Semi‐adjacent sections were labelled with 3 H‐PIB (Pittsburgh compound‐B, 2‐[4′‐(methylamino)phenyl]‐6‐hydroxybenzothiazole) and 14 C‐SB13 (4‐N‐methylamino‐4′‐hydroxystilbene) for comparison. Neocortical sections containing widespread senile plaques and cerebrovascular amyloid angiopathy, produced a sparse and weak labelling following incubation with 3 H‐FDDNP. Furthermore, in sections containing NFTs, there was no overt labelling of the pathology by 3 H‐FDDNP. In contrast, sections labelled with 3 H‐PIB displayed extensive labelling of diffuse plaques, classical plaques, cerebrovascular amyloid angiopathy and NFTs. 14 C‐SB13 produced a broadly similar binding pattern to PIB. Radioligand binding assays employing in vitro generated amyloid‐β peptide fibrils demonstrated a ∼10‐fold reduced affinity for 3 H‐FDDNP (85.0 ± 2.0 nM) compared with 3 H‐PIB (8.5 ± 1.3 nM). These data provide an alternative mechanistic explanation for the observed low cortical uptake of 18 F‐FDDNP in AD; in that the ligand is only weakly retained by the hallmark neuropathology because of its low affinity for amyloid structures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2009.05996.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 137

Metadata

Authors
Thompson, P. W., Ye, L., Morgenstern, J. L., Sue, L., Beach, T. G., Judd, D. J., Shipley, N. J., Libri, V., & Lockhart, A.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2009-03-18
Volume
109
Issue
2
Pages
623-630
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2082313481
Cited by
137
References
7
FWCI
9.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies. https://app.cochat.ai/papers/10.1111/j.1471-4159.2009.05996.x
The paper
Thompson, P. W., Ye, L., Morgenstern, J. L., Sue, L., Beach, T. G., Judd, D. J., Shipley, N. J., Libri, V., & Lockhart, A. (2009). Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2009.05996.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.